{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:06:06Z","timestamp":1789398366442,"version":"build-2803163510"},"reference-count":20,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background: Male breast lymphoma is rare, and most evidence on prognosis and treatment comes from female-predominant or mixed cohorts. We evaluated clinicopathological characteristics and cancer-specific survival (CSS) in men with lymphoma recorded as the primary breast site in SEER. Methods: Male patients diagnosed between 2000 and 2021 with lymphoma recorded as the primary breast site in SEER were identified. CSS was estimated using Kaplan\u2013Meier methods and compared with the log-rank test. Cox proportional hazards models were used to explore factors associated with CSS. Results: A total of 138 male patients were included. Most patients were aged \u226565 years (62.3%). Diffuse large B-cell lymphoma was the most common histological subtype (39.1%), followed by mucosa-associated lymphoid tissue (MALT) lymphoma (23.9%) and follicular lymphoma (17.4%). Among patients with known Ann Arbor stage, stage I disease was the most frequent presentation (48.8%). Chemotherapy was recorded in 44.9% of patients and radiotherapy in 31.2%. In univariable analysis, age (p &lt; 0.001), histological subtype (p &lt; 0.001), stage (p = 0.040), radiotherapy (p = 0.038), and chemotherapy (p = 0.020) were associated with CSS. Primary breast surgery was not associated with CSS (p = 0.556). Conclusions: In this SEER-based study of 138 men with breast lymphoma, older age and aggressive histology were independently associated with poorer CSS. Stage and treatment variables showed associations mainly in univariable analysis. These findings should be interpreted cautiously because of missing data, treatment-selection bias, and the lack of detailed treatment information in SEER. This study provides one of the largest and most updated male-only SEER analyses of this rare disease. Larger collaborative datasets with clinical, pathological, molecular, and treatment details are needed to better define prognosis and support individualized treatment.<\/jats:p>","DOI":"10.3390\/jcm15187136","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:15:04Z","timestamp":1789395304000},"page":"7136","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinicopathological Characteristics and Survival Outcomes of Male Breast Lymphoma"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5068-6472","authenticated-orcid":false,"given":"Abdulmunir","family":"Azizy","sequence":"first","affiliation":[{"name":"Medical Oncology, Istanbul University Institute of Oncology, Istanbul 34093, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"software","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1018-1119","authenticated-orcid":false,"given":"Izzet","family":"Dogan","sequence":"additional","affiliation":[{"name":"Medical Oncology, Acibadem Healthcare Group, Istanbul 34457, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"software","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"given":"Mustafa","family":"Bozkurt","sequence":"additional","affiliation":[{"name":"Medical Oncology, Acibadem Healthcare Group, Istanbul 34457, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6427-9077","authenticated-orcid":false,"given":"Onur","family":"Dulgeroglu","sequence":"additional","affiliation":[{"name":"General Surgery, Acibadem Healthcare Group, Istanbul 34457, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"validation","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4948-8927","authenticated-orcid":false,"given":"Serap","family":"Yucel","sequence":"additional","affiliation":[{"name":"Radiation Oncology, Acibadem Healthcare Group, Istanbul 34457, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"}]},{"given":"Ibrahim","family":"Yildiz","sequence":"additional","affiliation":[{"name":"Medical Oncology, Acibadem Healthcare Group, Istanbul 34457, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3122-4499","authenticated-orcid":false,"given":"Irmak Durur","family":"Subasi","sequence":"additional","affiliation":[{"name":"Radiology, Acibadem Healthcare Group, Istanbul 34457, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Arican","sequence":"additional","affiliation":[{"name":"Medical Oncology, Acibadem Healthcare Group, Istanbul 34457, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"}]},{"given":"Cihan","family":"Uras","sequence":"additional","affiliation":[{"name":"General Surgery, Acibadem Healthcare Group, Istanbul 34457, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"software","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1002\/1097-0142(197206)29:6<1705::AID-CNCR2820290640>3.0.CO;2-I","article-title":"Primary lymphoma of the breast","volume":"29","author":"Wiseman","year":"1972","journal-title":"Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5114\/aoms.2011.20600","article-title":"Primary breast lymphoma\u2014A review of the literature and report of three cases","volume":"7","author":"Joks","year":"2011","journal-title":"Arch. Med. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Zhang, J., Ma, B., Ji, H., and Guo, R. (2022). Primary breast lymphoma in males: Incidence, demographics, prognostic factors, survival, and comparisons with females. Front. Surg., 9.","DOI":"10.3389\/fsurg.2022.984497"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.breast.2003.11.002","article-title":"Primary breast lymphoma in a male patient","volume":"13","author":"Mpallas","year":"2004","journal-title":"Breast"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1093\/annonc\/mdt192","article-title":"Primary diffuse large B-cell lymphoma of the breast: Looking at pathogenesis, clinical issues and therapeutic options","volume":"24","author":"Aviv","year":"2013","journal-title":"Ann. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/annonc\/mdm471","article-title":"Primary diffuse large B-cell lymphoma of the breast: Prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group","volume":"19","author":"Ryan","year":"2008","journal-title":"Ann. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/bjh.12753","article-title":"A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era","volume":"165","author":"Hosein","year":"2014","journal-title":"Br. J. Haematol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3324\/haematol.10892","article-title":"Rituximab and dose dense chemotherapy in primary breast lymphoma","volume":"92","author":"Neri","year":"2007","journal-title":"Haematologica"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.2147\/OTT.S108839","article-title":"Primary breast diffuse large B-cell lymphoma in the era of rituximab","volume":"9","author":"Zhang","year":"2016","journal-title":"OncoTargets Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1148\/rg.2019180097","article-title":"Primary and secondary breast lymphoma: Clinical, pathologic, and multimodality imaging review","volume":"39","author":"Raj","year":"2019","journal-title":"Radiographics"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of mature lymphoid neoplasms: A report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.ctrv.2014.05.010","article-title":"Primary breast lymphoma","volume":"40","author":"Cheah","year":"2014","journal-title":"Cancer Treat. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/leu.2015.43","article-title":"Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphoma","volume":"29","author":"Horn","year":"2015","journal-title":"Leukemia"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"635","DOI":"10.6004\/jnccn.2022.7014","article-title":"Frailty in patients with newly diagnosed diffuse large B-cell lymphoma receiving curative-intent therapy: A population-based study","volume":"20","author":"Vijenthira","year":"2022","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood.2021013998","article-title":"Limited-stage diffuse large B-cell lymphoma","volume":"139","author":"Hawkes","year":"2022","journal-title":"Blood"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00428-019-02702-w","article-title":"The broad and challenging landscape of extranodal lymphoproliferations","volume":"476","author":"Dotlic","year":"2020","journal-title":"Virchows Arch."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1182\/blood-2010-03-276246","article-title":"Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: A study by the Groupe d\u2019Etudes des Lymphomes de l\u2019Adulte","volume":"116","author":"Coiffier","year":"2010","journal-title":"Blood"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.annonc.2025.07.014","article-title":"Lymphomas: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"36","author":"Eyre","year":"2025","journal-title":"Ann. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: The Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/18\/7136\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:23:25Z","timestamp":1789395805000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/18\/7136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":20,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["jcm15187136"],"URL":"https:\/\/doi.org\/10.3390\/jcm15187136","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]}}}